Web Toolbar by Wibiya
Login | Sign Up AnonymousUser
twiter
New to Comunitee?


or Sign Up with Email

Business

>> SHIRE PLC Latest News

SEP 17, 2014 - Zacks Investment Research

A Must Read - Share

Shire's Vyvanse Accepted for FDA Review for Binge Eating - Analyst Blog

Shire plc (SHPG) recently announced that the FDA has accepted its filing with priority review a supplemental New Drug Application (sNDA) for Vyvanse for treating adults with binge eating disorder.

Tags: Shire's Vyvanse Accepted for FDA Review for Binge Eating - Analyst Blog,  Shire Plc Latest News